Medicare Enrolled
Dr. Kevin Hunger, MD
Hematology & Oncology · Jacksonville, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hunger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hunger?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hunger
Dr. Kevin Hunger is a hematology & oncology specialist in Jacksonville, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Hunger performed 43,402 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hunger received a total of $2,536 from 53 pharmaceutical and/or device companies across 154 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hunger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 18% volume in FL
$2,536 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗43,402
Medicare services
Top 18% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
29,250 | $1 | $4 |
| Denosumab injection (Prolia/Xgeva) | 4,020 | $18 | $42 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,700 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,369 | $8 | $18 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,254 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,111 | $8 | $41 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
970 | $6 | $27 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
640 | $64 | $104 |
| Anti-nausea injection (Aloxi/palonosetron) | 560 | $1 | $75 |
| Injection, granisetron hydrochloride, 100 mcg | 430 | $0 | $41 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
414 | $97 | $162 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
296 | $22 | $90 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
188 | $99 | $355 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
166 | $10 | $42 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
155 | $7 | $280 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
126 | $22 | $80 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
118 | $25 | $84 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
113 | $44 | $160 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
93 | $70 | $70 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
70 | $63 | $115 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
63 | $1 | $4 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
43 | $3 | $15 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
42 | $122 | $265 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
42 | $42 | $74 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
36 | $25 | $130 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
32 | $12 | $55 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
20 | $28 | $74 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $103 | $225 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
14 | $46 | $310 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
13 | $48 | $500 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 13 | $401 | $1,000 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
12 | $174 | $535 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
11 | $1,098 | $2,400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
68.9% high complexity
22.2% medium
8.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,536
Total received (2018-2024)
Avg $362/year across 7 years
Bottom 41% in FL for hematology & oncology
53
Companies
154
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$597
2023
$263
2022
$134
2021
$229
2020
$313
2019
$624
2018
$375
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$150
SEAGEN INC.
$100
PFIZER INC.
$83
Boston Scientific Corporation
$49
GENZYME CORPORATION
$41
Eisai Inc.
$31
Napo Pharmaceuticals Inc
$24
Celgene Corporation
$19
Tempus AI, Inc
$17
Alexion Pharmaceuticals, Inc.
$15
Janssen Biotech, Inc.
$15
Daiichi Sankyo Inc.
$15
Agios Pharmaceuticals, Inc.
$13
JAZZ PHARMACEUTICALS INC.
$13
ARRAY BIOPHARMA INC
$12
Top 3 companies account for 55.7% of 2024 payments
All-time payments by company (2018-2024) ›
Octapharma USA, Inc.
$248
PFIZER INC.
$239
Novartis Pharmaceuticals Corporation
$226
Janssen Biotech, Inc.
$219
Merck Sharp & Dohme Corporation
$191
Boston Scientific Corporation
$181
SEAGEN INC.
$100
Astellas Pharma US Inc
$98
Daiichi Sankyo Inc.
$95
Eisai Inc.
$69
Foundation Medicine, Inc.
$61
GENZYME CORPORATION
$41
Incyte Corporation
$40
Alexion Pharmaceuticals, Inc.
$37
Kyowa Kirin, Inc.
$32
Genentech USA, Inc.
$31
Lexicon Pharmaceuticals, Inc.
$30
AMAG Pharmaceuticals, Inc.
$28
Ipsen Biopharmaceuticals, Inc
$28
Agios Pharmaceuticals, Inc.
$27
Napo Pharmaceuticals Inc
$24
Regeneron Healthcare Solutions, Inc.
$23
AVEO Pharmaceuticals, Inc.
$23
Sirtex Medical Inc
$22
EMD Serono, Inc.
$20
Karyopharm Therapeutics Inc.
$19
Amgen Inc.
$19
Celgene Corporation
$19
G1 Therapeutics, Inc.
$19
TerSera Therapeutics LLC
$18
Emmaus Medical, Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
EISAI INC.
$18
Janssen Pharmaceuticals, Inc
$17
Tempus AI, Inc
$17
MorphoSys, US Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Alnylam Pharmaceuticals Inc.
$14
JAZZ PHARMACEUTICALS INC.
$13
Array BioPharma Inc.
$13
Merck Sharp & Dohme LLC
$12
ARRAY BIOPHARMA INC
$12
INSYS Therapeutics Inc
$12
PUMA BIOTECHNOLOGY, INC.
$12
Gilead Sciences, Inc.
$12
Lilly USA, LLC
$12
GlaxoSmithKline, LLC.
$11
Pharmacyclics LLC, An AbbVie Company
$11
Exelixis Inc.
$11
Secura Bio, Inc.
$11
Clovis Oncology, Inc.
$10
Rigel Pharmaceuticals, Inc.
$5
Top 3 companies account for 28.1% of all-time payments
Associated products mentioned in payments ›
ALIMTA · Alecensa · BOSULIF · BRAFTOVI · Balversa · Bavencio · Braftovi · CABLIVI · CABOMETYX · COSELA · DARZALEX · ELIQUIS · EMBLEM MRI S-ICD · EMEND · ENJAYMO · ERLEADA · Endari · Enhertu · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · GELCLAIR CONCENTRATED ORAL GEL · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · Imbruvica · JAKAFI · KEYTRUDA · KISQALI · LIBTAYO · LUX-Dx Insertable Cardiac Monitor · Lenvima · MEKINIST · MONJUVI · NERLYNX · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPDUALAG · PADCEV · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Phesgo · REBLOZYL · RESONATE EL ICD VR · RYBREVANT · Rezlidhia · Rubraca · SANCUSO · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · SYNDROS · Stivarga · TABRECTA · TASIGNA · TIVDAK · ULTOMIRIS · Ultomiris · VYNDAQEL · Vectibix · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
106
County median income
$68,447
Nearest hospital to ZIP centroid (approximate)
ASCENSION ST VINCENT'S RIVERSIDE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hunger is a mixed practice specialist, with above-average Medicare volume (top 18% in FL), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hunger experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Hunger performed 29,250 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hunger receive payments from pharmaceutical companies?
Yes. Dr. Hunger received a total of $2,536 from 53 companies across 154 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hunger's costs compare to other hematology & oncology specialists in Jacksonville?
Dr. Hunger's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hunger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Jacksonville
Browse hematology & oncology specialists in Jacksonville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Octapharma USA, Inc. Payments to Doctors
See all physicians who received payments from Octapharma USA, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology